CI vs COLL
Cigna Corp (CI) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CI currently screens at market cap $71.62B and trailing P/E 2.4. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CI and COLL stock pages for the full models.
Not investment advice.